Skip to main content
. 2014 Oct 28;111(12):2268–2274. doi: 10.1038/bjc.2014.554

Table 6. Patient details for PR or prolonged SD.

Pt # Eribulin mesylate dose mg m−2 per cisplatin dose mg m−2 (schedule) Response Disease site Weeks on treatment
1
1.0/60 (28d)
PR
Pancreatic
18 (Off for PD)
2
1.2/60 (28d)
PR
Breast
24 (Off for PD)
3
1.4/60 (21d)
PR
Oesophagus
17 (Off for PD)
4
1.2/75 (21d)
PR
Bladder
17 (Off due to surgery)
5
1.0/60 (28d)
SD
Head/neck
25 (Off for pt refusal)
6
1.2/60 (28d)
SD
Appendix
30 (Off for MD discretion)
7
1.2/60 (28d)
SD
Head/neck
16 (Off for pt refusal)
8
1.2/60 (28d)
SD
Ovary
32 (Off for PD)
9
1.2/60 (28d)
SD
Lung
21 (Off for MD discretion)
10
1.2/60 (28d)
SD
Lung
11 (Off for Pt refusal)
11
1.4/60 (28d)
SD
Lung
31 (Off for PD)
12
1.4/60 (21d)
SD
Pancreas
18 (Off for PD)
13
1.4/60 (21d)
SD
Lung
23 (Off for Tox)
14
1.4/60 (21d)
SD
Head/neck
27 (Off for PD)
15
1.2/75 (21d)
SD
Head/neck
28 (Off for PD)
16
1.2/75 (21d)
SD
Lung
24 (Off for MD discretion)
17 1.2/75 (21d) SD Head/neck 21 (off for Pt refusal)

Abbreviations: PD=progressive disease; PR=partial response; SD=stable disease; prolonged SD=prolonged stable disease (stable disease for six cycles or more or stable disease and off treatment due to patient refusal or MD discretion).